Deficiency in mouse oxytocin prevents milk ejection, but not fertility or parturition

Journal of Neuroendocrinology

Volumn 8, Issue 11, 1996, Pages 847-853

  Young III, W Scott ^a,d   Shepard, Emily ^a   Amico, Janet ^c   Hennighausen, Lothar ^b   Wagner, Kay Uwe ^b   Lamarca, Mary E ^a   McKinney, Cindy ^a   Ginns, Edward I ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b NATIONAL INSTRUMENTS   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d MSC 4068 ^*  (United States)

Author keywords

Homologous recombination; Lactation; Mammary gland; Reproduction paraventricular; Supraoptic

Indexed keywords

NEUROPHYSIN; OXYTOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHILDBIRTH; CONTROLLED STUDY; FEMALE; FERTILITY; GENE DELETION; HORMONE DEFICIENCY; LACTATION; MALE; MATING; MEMORY; MILK EJECTION; MOUSE; NEUROHYPOPHYSIS; NONHUMAN; PRIORITY JOURNAL; SUPRAOPTIC NUCLEUS; THALAMUS MIDLINE NUCLEUS;

ANIMALS; FEMALE; FERTILIZATION; HETEROZYGOTE; HOMOZYGOTE; LABOR, OBSTETRIC; LACTATION; MALE; MICE; MICE, INBRED C57BL; MUTATION; OXYTOCIN; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PITUITARY GLAND, POSTERIOR; PREGNANCY; REFERENCE VALUES; SUPRAOPTIC NUCLEUS; TRANSCRIPTION, GENETIC;

EID: 0029853075     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2826.1996.05266.x     Document Type: Article

References (63)

1. Oliver G. Schäfer EA. On the physiological action of extracts of pituitary body and certain other glandular organs. J Physiol (Lond) 1995; 18: 277-279.
2. Dale HH. The actions of extracts of the pituitary body. Biochem J 1990; 4: 427-447.
3. Ott I, Scott JC. The action of the infundibulin upon the mammary secretion. Proc Soc Exp Biol Med 1911; 8: 48-49.
4. Bargmann W, Scharrer E. The origin of the poterior pituitary hormones. Am Scientist 1951; 39: 255-259.
5. Du Vigneaud V. Hormones of the posterior pituitary gland: oxytocin and vasopressin. Harvey Lect 1954; 50: 1-26.
6. Swaab DF, Pool CW, Nijveldt F. Immunofluorescence of vasopressin and oxytocin in the rat hypothalamo-neurohypophysial system. J Neural Transmission 1975; 36: 195-215.
7. Vandesande F, Dierickx K. Identification of the vasopressin producing and of the oxytocin producing neurons in the hypothalamic magnocellular neurosecretory system of the rat. Cell Tiss Res 1975; 164: 153-162.
8. Brownstein MJ, Russell JT, Gainer H. Synthesis, transport and release of posterior pituitary hormones. Science 1980; 207: 373-387.
9. Land H, Schutz G, Schmale H. et al. Nucleotide sequence of cloned cDNA encoding bovine arginine vasopressin-neurophysin II precursor. Nature 1982; 295: 299-303.
10. Land H, Grez M, Ruppert S. et al. Deduced amino acid sequence from the bovine oxytocin-neurophysin I precursor cDNA. Nature 1983; 302: 342-344.
11. Young WS, III. Expression of the oxytocin and vasopressin genes. J Neuroendocrinol 1992; 5: 527-540.
12. Russell JA, Leng G, Bicknell RJ. Opioid tolerance and dependence in the magnocellular oxytocin system: a physiological mechanism? Exp Physiol 1995; 80: 307-340.
13. Pederson CA, Prange AJJ. Induction of maternal behavior in virgin rats after intracerebroventricular administration of oxytocin. Proc Natl Acad Sci (USA) 1979; 76: 6661-6665.
14. van Leengoed E, Kerker E, Swanson HH. Inhibition of post-partum maternal behaviour in the rat by injecting an oxytocin antagonist in the cerebral ventricles. J. Endocrinol 1987; 112: 275-282.
15. Pederson CA, Caldwell JD, Jirikowski GF. et al. (eds). Oxytocin in Maternal, Sexual, and Social Behaviors. Ann N Y Acad Sci 1992; 652.
16. Insel T. Oxytocin a neuropeptide for affiliation: evidence from behavioral, receptor autoradiographic, and comparative studies. Psychoneuroendocrinology 1992; 17: 3-35.
17. Witt DM. Oxytocin and rodent sociosexual responses: from behavior to gene expresson. Neurosci Biobehav Rev 1995; 19: 315-324.
18. Verbalis JG, Mangione MP, Stricker EM. Oxytocin produces natriuresis in rats at physiological plasma concentrations. Endocrinology 1991; 128: 1317-1322.
19. Chou C-L, DiGiovanni SR, Mejia R. et al. Oxytocin as an antidiuretic hormone: I. Concentration dependence of action. Am J Physiol 1995; 269: F70-77.
20. de Wied D, Elands J, Kovács G. Interactive effects of neurohypophyseal neuropeptides with receptor antagonists on a passive avoidance behavior: mediation by a cerebral neurohypophyseal hormone receptor? Proc Natl Acad Sci (USA) 1991; 88: 1494-1498.
21. Gale CC, McCann SM. Hypothalamic control of pituitary gonadotrophins. Impairment in gestation, parturition and milk ejection following hypothalamic lesions. J Endocrinol 1961; 22: 107-117.
22. Kumaresan P, Kagan A, Glick SM. Oxytocin antibody and lactation and parturition in rats. Nature 1971; 230: 468-469.
23. Melin P. Oxytocin antagonists in preterm labour and delivery. Baillières Clin Obstet Gynaecol 1993; 7: 577-600.
24. Goodwin TM, Paul R, Silver H. et al. The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human. Am J Obstet Gynecol 1994; 170: 474-478.
25. Antonijevic IA, Douglas AJ, Dye S. et al. Oxytocin antagonists delay the initiation of paturition and prolong its active phase in rats. J Endocrinol 1995; 145: 97-103.
26. Hara Y, Battey J, Gainer H. Structure of mouse vasopressin and oxytocin genes. Mol Brain Res 1990; 8: 319-324.
27. Tybulewicz VL, Tremblay ML, LaMarca ME. et al. Animal model of Gaucher's disease from targeted disruption of the mouse glucocere-brosidase gene. Nature 1992; 357: 407-410.
28. Schmidt A, Jard S, Dreifuss JJ. et al. Oxytocin receptors in rat kidney during development. Am J Physiol 1990; 259: F872-F881.
29. Ostrowski NL, Young WS, III, Lolait SJ. Estrogen increases renal oxytocin receptor gene expression 1995; 136: (in press).
30. Lightman SL, Young WS, III. Vasopressin, oxytocin, dynorphin, enkephalin, and corticotrophin releasing factor mRNA stimulation in the rat. J Physiol (Lond) 1987; 394: 23-39.
31. Altstein M, Whitnall MH, House S. et al. An immunochemical analysis of oxytocin and vasopressin prohormone processing in vitro. Peptides 1988; 9: 87-105.
32. Amico JA. Oxytocin and oxytocin-like peptides in primate tissues and body fluids. In: Yoshida S, Share LS, ed. Recent Progress in Posterior Hormones, New York: Elsevier Science Publishers, 1988; 207-213.
33. Sausville E, Carney D, Battey J. The human vasopressin gene is linked to the oxytocin gene and is selectively expressed in a cultured lung cancer cell line. J Biol Chem 1985; 260: 10236-10241.
34. Watson SJ, Akil H, Fischli W. et al. Dynorphin and vasopressin: common localization in magnocellular neurons. Science 1982; 216: 85-87.
35. Tramu G, Croix C, Pillez A. Ability of CRF immunoreactive neurons of the paraventricular nucleus to produce a vasopressin-like material. Neuroendocrinology 1983; 37: 467-469.
36. Kiss JZ, Mezey É. Skirboll L. Corticotropin-releasing factor-immunoreactive neurons of the paraventricular nucleus become vasopressin positive after adrenalectomy. Proc Natl Acad Sci (USA) 1984; 81: 1854-1858.
37. Sawchenko PE, Swanson LW, Vale WW. Co-expression of corticotropin-releasing factor and vasopressin immunoreactivity in parvocellular neurosecretory neurons of the adrenalectomized rat. Proc Natl Acad Sci (USA) 1984; 81: 1883-1887.
38. Young WS, III. Corticotropin-releasing factor mRNA in the hypothalamus is affected differently by drinking saline and by dehydration. FEBS Lett 1986; 208: 158-162.
39. Lightman SL, Young WS, III. Changes in hypothalamic preproenkephalin A mRNA following stress and opiate withdrawal. Nature 1987; 328: 643-645.
40. Young WS, III, Lightman SL. Chronic stress elevates enkephalin expression in the paraventricular and supraoptic nuclei. Mol Brain Res 1991; 13: 111-117.
41. Liggens GC. Hormonal interactions in the mechanism of parturition. In: Klopper A, Gardner JS, ed. Endocrine Factors in Labour, London: Cambridge University Press, 1977: 119-139.
42. Smyth CN. The oxytocin sensitivity test. In: Pinkerton JHMs, ed. Advances in Oxytocin Research, London: Pergammon, 1965: 115-123.
43. Theobald GW, Robards MF, Suter PEN. Changes in myometrial sensitivity to oxytocin in man during the last six weeks of pregnancy. J Obstet Gynaecol Br Commonw 1969; 76: 385-393.
44. Soloff MS, Schroeder BT, Chakraborty J, Pearlmutter AF. Characterization of oxytocin receptors in the uterus and mammary gland. Fed Proc 1977; 36: 1861-1866.
45. Lefebvre DL, Giaid A, Bennett H. et al. Oxytocin gene expression in rat uterus. Science 1992; 256: 1553-1555.
46. Chibbar R. Miller FD. Mitchell BF. Synthesis of oxytocin in amnion, chorion, and decidua may influence the timing of human parturition. J Clin Invent 1993; 91: 185-192.
47. Manning M, Sawyer WH. Design, synthesis, and some uses of receptor-specific agonists and antagonists of vasopressin and oxytocin. J Receptor Res 1993; 13: 195-214.
48. Glasier A, McNeilly AS. Physiology of lactation. Baillière's Clin Endocrinol Metab 1990; 4: 379-395.
49. Crowley WR, Armstrong WE. Neurochemical regulation of oxytocin secretion in lactation. Endocr Rev 1992; 13: 33-65.
50. Wakerly JB, Clarke G, Summerlee AJS. Milk ejection and its control. In: Knobil E, Neill Js, ed. The Physiology of Reproduction New York: Raven Press, 1988: 2283-2323.
51. Clarke G, Wood P, Merrick L, Lincoln DW. Opiate inhibition of peptide release from the neurohumoral termlinals of hypothalamic neurones. Nature 1979; 282: 746-748.
52. Iversen LL, Iversen SD, Bloom FE. Opiate receptors influence vasopressin release from nerve terminals in rat neurohypophysis. Nature 1980; 284: 350-351.
53. Lightman SL, Iversen LL, Forsling ML. Dopamine and [D-Ala2, D-Leu5]enkephalin inhibit the electrically stimulated neurohypophyseal release of vasopressin in vitro: evidence for calcium-dependent opiate action. J Neurosci 1982; 2: 78-81.
54. Maysinger D, Vermes I, Tilders F. et al. Differential effects of various opioid peptides on vasopressin and oxytocin release from the pituitary in vitro. Arch Pharmacol 1984; 328: 191-195.
55. Bondy CA, Gainer H, Russell JT. Dynorphin A inhibits and naloxone increases the electrically stimulated release of oxytocin but not vasopressin from the terminals of the neural lobe. Endocrinology 1988; 122: 1321-1327.
56. Falke N. Dynorphin (1-8) inhibits stimulated release of oxytocin but not vasopressin from isolated neurosecretory endings of the rat neurohypophysis. Neuropeptides 1988; 11: 163-167.
57. Summy-Long JY, Rosella-Dampman LM, McLemore GL, Koehler E. Kappa opiate receptors inhibit release of oxytocin from the magnocellular system during dehydration. Neuroendocrinology 1990; 51: 376-384.
58. Zhao B, Chapman C, Bicknell RJ. Opioid-noradrenergic interactions in the neurohypophysis. I. Differential opioid receptor regulation of oxytocin, vasopressin, and noradrenaline release. Neuroendocrinology 1988; 48: 16-24.
59. Tybulewicz VL, Crawford CE, Jackson PK. et al Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 1991; 65: 1153-63.
60. Ben-Barak Y, Russell JT, Whitnall MH. et al. Phylogenetic cross-reactivities of monoclonal antibodies produced against rat neurophysin. Cell Mol Neurobiol 1984; 4: 339-349.
61. Amico JA, Seif SM, Robinson AG. Oxytocin in human plasma-correlation with neurophysin and stimulation with estrogen. J Clin Endocrin Melab 1981; 52: 988-993.
62. Amico JA, Ervin MG, Leake RD. et al. A Novel oxytocin-like and vasotocin-like peptide in human plasma after administration of estrogen. J Clin Endocrin Metab 1985; 60: 5-12.
63. Kordon EC, McKnight RA, Jhappan C. et al. Ectopic TGFb1 expression in the secretory mammary epithelium induces early senescence of the epithelial stem cell population. Dev Biol 1995; 167: 47-61.